首页 > 市场调查报告书 > 医疗设备

医学影像诊断核子医学

市场调查报告书

商品编码

1633546

核子医学影像设备市场规模、份额和成长分析（按技术、产品类型、应用、最终用户和地区）- 产业预测，2025-2032 年

Nuclear Imaging Devices Market Size, Share, Growth Analysis, By Technology (Single-Photon Emission Computed Tomography, Positron Emission Tomography ), By Product Type, By Application, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2025年01月12日 | 出版商:

SkyQuest | 英文 228 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计2023年全球核医影像设备市场规模将达23亿美元，将从2024年的24.7亿美元成长到2032年的44.1亿美元，预测期间（2025-2032年）的复合年增长率为7.5%。

受医学影像技术进步和慢性病发病率上升的推动，全球核医学影像设备市场正在强劲成长。老龄化社会，特别是更容易患与老龄化相关的疾病的社会，正在推动这一市场的发展，同时肿瘤学、心臟病学和神经病学领域的应用也在不断增加。将 PET 或 SPECT 与 CT 结合的混合成像系统的普及透过提供全面的解剖和功能见解增强了诊断能力。此外，人工智慧和机器学习的融合正在使这些设备更有效率、更准确。然而，高成本和某些地区的报销限制等挑战可能会阻碍扩张。儘管如此，随着医疗保健基础设施的发展并最终改善患者的治疗效果，创新和策略伙伴关係仍存在重大机会。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲国家
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前 5 家公司对比
主要企业市场定位（2024年）
主要市场参与者所采用的策略
近期市场趋势
公司市场占有率分析（2024 年）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分析市场份额
- 收益与前一年同期比较（2022-2024 年）

主要企业简介

GE HealthCare Technologies（United States）
Siemens Healthineers（Germany）
Philips Healthcare（Netherlands）
Canon Medical Systems Corporation（Japan）
Neusoft Medical Systems Co., Ltd.（China）
Mediso Ltd.（Hungary）
Digirad Corporation（United States）
CMR Naviscan Corporation（United States）
Shimadzu Corporation（Japan）
PerkinElmer（United States）
MILabs BV（Netherlands）
MR Solutions Ltd.（United Kingdom）
SurgicEye GmbH（Germany）
Triad Isotopes（United States）
Cardinal Health（United States）
Lantheus Holdings（United States）
Medtronic（United States）
Bayer（Germany）
SHINE Technologies（United States）

结论和建议

简介目录

Product Code: SQMIG35A2604

Global Nuclear Imaging Devices Market size was valued at USD 2.3 billion in 2023 and is poised to grow from USD 2.47 billion in 2024 to USD 4.41 billion by 2032, growing at a CAGR of 7.5% during the forecast period (2025-2032).

The global nuclear imaging devices market is experiencing robust growth, fueled by advancements in medical imaging technology and a rising prevalence of chronic diseases. The aging population, especially susceptible to age-related conditions, along with increasing applications in oncology, cardiology, and neurology, propels this market forward. The surge in hybrid imaging systems, which integrate PET or SPECT with CT, enhances diagnostic capabilities by providing comprehensive anatomical and functional insights. Additionally, the integration of AI and machine learning is improving the efficiency and accuracy of these devices. However, challenges such as high costs and limited reimbursement in certain regions could hinder expansion. Despite this, substantial opportunities exist for innovation and strategic partnerships as healthcare infrastructures evolve, ultimately enhancing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nuclear Imaging Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nuclear Imaging Devices Market Segmental Analysis

Global Nuclear Imaging Devices Market is segmented by Technology, Product Type, Application, End User and region. Based on Technology, the market is segmented into Single-Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET). Based on Product Type, the market is segmented into PET Devices, SPECT Devices and Planar Imaging Devices. Based on Application, the market is segmented into Oncology, Cardiology, Neurology and Others. Based on End User, the market is segmented into Hospitals, Imaging Centers, Academic and Research Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nuclear Imaging Devices Market

The global nuclear imaging devices market is significantly driven by rapid technological advancements, including the emergence of hybrid imaging systems and molecular imaging methods that greatly improve diagnostic accuracy and efficiency. These innovations empower healthcare professionals to gain deeper insights into the functioning of organs and tissues, thereby enhancing patient outcomes. Moreover, the incorporation of artificial intelligence (AI) and machine learning algorithms into these imaging devices is further elevating image quality and diagnostic capabilities, enabling medical practitioners to make more informed decisions. As a result, these cutting-edge developments are playing a crucial role in steering the growth of the nuclear imaging devices market worldwide.

Restraints in the Global Nuclear Imaging Devices Market

The global nuclear imaging devices market faces significant restraints primarily due to the high costs associated with these technologies. The initial capital investment for purchasing and installing nuclear imaging devices, along with ongoing maintenance expenses, can be substantial. This financial burden particularly affects developing regions where healthcare budgets are constrained. Moreover, the expenses related to radioactive isotopes utilized in imaging procedures further escalate overall costs. As a result, the high pricing acts as a deterrent for market entry and can hinder the widespread adoption of these devices, especially among healthcare facilities facing financial limitations. Addressing these cost-related issues is crucial for promoting market growth.

Market Trends of the Global Nuclear Imaging Devices Market

The Global Nuclear Imaging Devices market is witnessing a notable trend towards the growing demand for hybrid imaging systems, which merge modalities like positron emission tomography (PET) or single-photon emission computed tomography (SPECT) with computed tomography (CT) or magnetic resonance imaging (MRI). This integration delivers comprehensive anatomical and functional insights in one scan, enhancing disease characterization and treatment planning. Healthcare professionals benefit from the ability to accurately pinpoint abnormalities, assess their metabolic activity, and evaluate their effects on adjacent tissues. This trend is fueled by a push for improved diagnostic accuracy and personalized medicine, positioning hybrid systems as critical tools in modern healthcare.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Nuclear Imaging Devices Market Size by Technology & CAGR (2025-2032)

Market Overview
Single-Photon Emission Computed Tomography (SPECT)
Positron Emission Tomography (PET)

Global Nuclear Imaging Devices Market Size by Product Type & CAGR (2025-2032)

Market Overview
PET Devices
- Standalone PET
- PET/CT
- PET/MRI
SPECT Devices
- Standalone SPECT
- SPECT/CT
- SPECT/MRI
Planar Imaging Devices

Global Nuclear Imaging Devices Market Size by Application & CAGR (2025-2032)

Market Overview
Oncology
Cardiology
Neurology
Others

Global Nuclear Imaging Devices Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Imaging Centers
Academic and Research Centers
Others

Global Nuclear Imaging Devices Market Size & CAGR (2025-2032)

North America (Technology, Product Type, Application, End User)
- US
- Canada
Europe (Technology, Product Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Product Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Product Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Product Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

GE HealthCare Technologies (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neusoft Medical Systems Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mediso Ltd. (Hungary)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Digirad Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CMR Naviscan Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MILabs B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MR Solutions Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SurgicEye GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Triad Isotopes (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lantheus Holdings (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SHINE Technologies (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments